Ablukast
Appearance
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C28H34O8 |
Molar mass | 498.572g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Ablukast(INN) is an experimental drug that is aleukotriene antagonist.It was investigated for potential applications in the treatment of inflammatory conditions, including asthma, skin disorders, and inflammatory bowel disease.[1][2]It reached Phase III clinical trials, butdevelopmentwas discontinued in 1996.[2]
References
[edit]- ^Rosenbach T, Csatò M, Czarnetzki BM (January 1988). "Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis".The British Journal of Dermatology.118(1): 1–6.doi:10.1111/j.1365-2133.1988.tb01743.x.PMID2829957.S2CID1164113.
- ^ab"Ablukast".Adis Insight.
External links
[edit]Media related toAblukastat Wikimedia Commons